Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8+ T cells in the nigra of hemiparkinsonian monkey

Neuroscience

Volumn 302, Issue , 2015, Pages 36-46

  Roy, A ^a   Mondal, S ^a   Kordower, J H ^a   Pahan, K ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Hemiparkinsonian monkeys; Microglia; Neuroinflammation; Parkinson's disease; RANTES; T cell infiltration

Indexed keywords

EOTAXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEMO BINDING DOMAIN PEPTIDE; PROTEIN INHIBITOR; RANTES; UNCLASSIFIED DRUG; AIF1 PROTEIN, HUMAN; CCAAT BINDING FACTOR; CYTOKINE; DNA BINDING PROTEIN; LEUKOCYTE ANTIGEN; NBD PEPTIDE, MOUSE; NFYB PROTEIN, MOUSE; PEPTIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; MICROGLIA; MOUSE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; RHESUS MONKEY; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SUBSTANTIA NIGRA;

ANIMALS; ANTIGENS, CD; CCAAT-BINDING FACTOR; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINE CCL11; CHEMOKINE CCL5; CYTOKINES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; MACACA MULATTA; MICE; MICROGLIA; PARKINSONIAN DISORDERS; PEPTIDES; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 84938294210     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.03.011     Document Type: Article

References (39)

1. Appay V., Rowland-Jones S.L. ANTES: a versatile and controversial chemokine. Trends Immunol 2001, 22:83-87.
2. Brahmachari S., Jana A., Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 2009, 183:5917-5927.
3. Brochard V., Combadiere B., Prigent A., Laouar Y., Perrin A., Beray-Berthat V., Bonduelle O., Alvarez-Fischer D., Callebert J., Launay J.M., Duyckaerts C., Flavell R.A., Hirsch E.C., Hunot S. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 2009, 119:182-192.
4. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., Rawlins J.N., Perry V.H. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 2009, 65:304-312.
5. Czlonkowska A., Kurkowska-Jastrzebska I., Czlonkowski A., Peter D., Stefano G.B. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide. Med Sci Monit 2002, 8:RA165-RA177.
6. Dasgupta S., Jana M., Liu X., Pahan K. Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells. J Biol Chem 2003, 278:22424-22431.
7. Dasgupta S., Jana M., Liu X., Pahan K. (Myelin basic protein-primed T cells of female but not male mice induce nitric-oxide synthase and proinflammatory cytokines in microglia: implications for gender bias in multiple sclerosis. J Biol Chem 2005, 280:32609-32617.
8. Dasgupta S., Roy A., Jana M., Hartley D.M., Pahan K. (Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha. Mol Pharmacol 2007, 72:934-946.
9. Denes A., Humphreys N., Lane T.E., Grencis R., Rothwell N. (Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J Neurosci 2010, 30:10086-10095.
10. Fahy O., Porte H., Senechal S., Vorng H., McEuen A.R., Buckley M.G., Walls A.F., Wallaert B., Tonnel A.B., Tsicopoulos A. (Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin. Am J Pathol 2001, 158:1053-1063.
11. Field R., Campion S., Warren C., Murray C., Cunningham C. Systemic challenge with the TLR3 agonist poly I: C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun 2010, 24:996-1007.
12. Ghosh A., Roy A., Liu X., Kordower J.H., Mufson E.J., Hartley D.M., Ghosh S., Mosley R.L., Gendelman H.E., Pahan K. (Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 2007, 104:18754-18759.
13. Ghosh A., Roy A., Matras J., Brahmachari S., Gendelman H.E., Pahan K. (Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease. J Neurosci 2009, 29:13543-13556.
14. Hadida F., Vieillard V., Autran B., Clark-Lewis I., Baggiolini M., Debre P. HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J Exp Med 1998, 188:609-614.
15. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
16. Hayden M.S., Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012, 26:203-234.
17. Hu S., Chao C.C., Ehrlich L.C., Sheng W.S., Sutton R.L., Rockswold G.L., Peterson P.K. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta. J Leukoc Biol 1999, 65:815-821.
18. Hunot S., Hirsch E.C. Neuroinflammatory processes in Parkinson's disease. Ann Neurol 2003, 53(Suppl. 3):S49-S58. [discussion S58-S60].
19. Jana M., Pahan K. (IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophages. Mol Immunol 2009, 46:773-783.
20. Jana M., Jana A., Liu X., Ghosh S., Pahan K. Involvement of phosphatidylinositol 3-kinase-mediated up-regulation of I kappa B alpha in anti-inflammatory effect of gemfibrozil in microglia. J Immunol 2007, 179:4142-4152.
21. Jana M., Dasgupta S., Pal U., Pahan K. IL-12 p40 homodimer, the so-called biologically inactive molecule, induces nitric oxide synthase in microglia via IL-12R beta 1. Glia 2009, 57:1553-1565.
22. Khasnavis S., Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J Neuroimmune Pharmacol 2012.
23. Khasnavis S., Roy A., Ghosh S., Watson R., Pahan K. (Protection of dopaminergic neurons in a mouse model of Parkinson's disease by a physically-modified saline containing charge-stabilized nanobubbles. J Neuroimmune Pharmacol 2014, 9:218-232.
24. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000, 290:767-773.
25. Kremlev S.G., Roberts R.L., Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 2004, 149:1-9.
26. Laurie C., Reynolds A., Coskun O., Bowman E., Gendelman H.E., Mosley R.L. CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neuroimmunol 2007, 183:60-68.
27. Lee J.K., Chung J., McAlpine F.E., Tansey M.G. Regulator of G-protein signaling-10 negatively regulates NF-kappaB in microglia and neuroprotects dopaminergic neurons in hemiparkinsonian rats. J Neurosci 2011, 31:11879-11888.
28. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000, 289:1550-1554.
29. Mondal S., Roy A., Jana A., Ghosh S., Kordower J.H., Pahan K. Testing NF-kappaB-based therapy in hemiparkinsonian monkeys. J Neuroimmune Pharmacol 2012, 7:544-556.
30. Pahan K., Sheikh F.G., Namboodiri A.M., Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997, 100:2671-2679.
31. Pahan K., Sheikh F.G., Liu X., Hilger S., McKinney M., Petro T.M. (Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J Biol Chem 2001, 276:7899-7905.
32. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 2007, 7:161-167.
33. Roy A., Fung Y.K., Liu X., Pahan K. Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 2006, 281:14971-14980.
34. Roy A., Jana A., Yatish K., Freidt M.B., Fung Y.K., Martinson J.A., Pahan K. Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: implications for neurodegenerative diseases. Free Radic Biol Med 2008, 45:686-699.
35. Roy A., Ghosh A., Jana A., Liu X., Brahmachari S., Gendelman H.E., Pahan K. Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease. PLoS ONE 2012, 7:e38113.
36. Terme M., Chaput N., Combadiere B., Ma A., Ohteki T., Zitvogel L. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J Immunol 2008, 180:4679-4686.
37. Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., Stan T.M., Fainberg N., Ding Z., Eggel A., Lucin K.M., Czirr E., Park J.S., Couillard-Despres S., Aigner L., Li G., Peskind E.R., Kaye J.A., Quinn J.F., Galasko D.R., Xie X.S., Rando T.A., Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477:90-94.
38. Wada T., Furuichi K., Sakai N., Shimizu M., Segawa C., Kobayashi K., Mukaida N., Kasahara T., Matsushima K., Yokoyama H. Eotaxin contributes to renal interstitial eosinophilia. Nephrol Dial Transplant 1999, 14:76-80.
39. Wei J., Wu F., Sun X., Zeng X., Liang J.Y., Zheng H.Q., Yu X.B., Zhang K.X., Wu Z.D.. Differences in microglia activation between rats-derived cell and mice-derived cell after stimulating by soluble antigen of IV larva from Angiostrongylus cantonensis in vitro. Parasitol Res 2013, 112:207-214.